High cholesterol is one of the leading risk factors for heart attack and stroke, yet many people do not know they have it until serious health problems develop. Over the past several years, researchers have learned more about who is most at risk for cardiovascular disease and how cholesterol-lowering treatments can prevent future complications.
The American Heart Association’s updated cholesterol guidance reflects these advances. Rather than focusing on cholesterol numbers alone, the recommendations place greater emphasis on a person’s overall cardiovascular risk, earlier prevention, and using the right treatment for the right patient. The goal is to identify people who can benefit from treatment before they experience a heart attack or stroke.
A Bigger Focus on Overall Cardiovascular Risk
One of the biggest changes in the updated guidance is that treatment decisions are no longer based only on LDL (“bad”) cholesterol levels.
Instead, healthcare providers are encouraged to look at a person’s overall risk of developing cardiovascular disease over the next 10 years. This includes factors such as:
- Age
- Blood pressure
- Smoking status
- Diabetes
- Family history of early heart disease
- Cholesterol levels
This means that two people with the same LDL cholesterol level may receive different treatment recommendations depending on their overall risk profile.
The guidelines also encourage discussions between patients and healthcare providers so treatment decisions can be individualized.
More People May Be Candidates for Statin Therapy
Statins remain the first-line medication for lowering LDL cholesterol and reducing the risk of heart attack and stroke.
The updated recommendations continue to strongly support statins for:
- People with established cardiovascular disease
- Adults with LDL cholesterol of 190 mg/dL or higher
- Most adults with diabetes between 40 and 75 years of age
- Adults with an elevated 10-year cardiovascular risk after discussing the benefits and risks with their healthcare provider
Rather than waiting until cholesterol reaches extremely high levels, the guidelines support earlier treatment in people whose overall cardiovascular risk is elevated.
Risk-Enhancing Factors Play a Larger Role
Another important change is the increased use of risk-enhancing factors when deciding whether medication is appropriate.
These include:
- A strong family history of premature heart disease
- Chronic kidney disease
- Metabolic syndrome
- Chronic inflammatory diseases
- Persistently elevated triglycerides
- Certain pregnancy-related conditions, such as preeclampsia or premature menopause
- High-risk ethnic backgrounds
These factors help identify people who may benefit from cholesterol-lowering treatment even if their calculated risk appears borderline.
The guidelines also recognize that additional testing, such as coronary artery calcium (CAC) scoring, may help clarify risk when the decision about starting a statin is uncertain.
Lifestyle Changes Remain the Foundation of Treatment
Although medications play an important role, the updated guidance emphasizes that healthy lifestyle habits remain the foundation of cholesterol management.
The recommendations encourage:
- Eating a heart-healthy diet rich in fruits, vegetables, whole grains, and healthy fats
- Limiting saturated fats, trans fats, and highly processed foods
- Exercising regularly
- Maintaining a healthy weight
- Avoiding tobacco products
- Managing blood pressure and diabetes
Even for people taking cholesterol-lowering medication, these lifestyle changes continue to provide important cardiovascular benefits.
What These Changes Mean for Patients
The updated cholesterol guidance represents a shift away from treating laboratory numbers alone and toward treating the whole person.
Rather than asking only, “What is your cholesterol level?” healthcare providers are now encouraged to ask, “What is your overall risk of developing heart disease?”
This approach allows treatment to be tailored more closely to each individual’s health profile. Some people may begin statin therapy earlier than they would have under older recommendations, while others may benefit from additional testing before making a treatment decision.
For patients, the message is clear: cholesterol management is no longer just about lowering a number. It is about reducing the overall risk of heart attack, stroke, and other cardiovascular diseases through a combination of healthy lifestyle choices, personalized risk assessment, and medication when appropriate.
Source
Arnett DK, Blumenthal RS, Albert MA, et al. 2025 American Heart Association Cholesterol Guideline Update. Circulation. 2025. Accessed by: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001423?__cf_chl_f_tk=fk8XsKEcJ.sAH6sWX26BSplsLXq1GqpPxd2Xm9C.Ii0-1782905829-1.0.1.1-2CeX0MSGEwNgsLpZKY962QLAsN3IkK7V2QpGCMT8sRw
